| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |